Enter the first few characters of Company and click 'Go'
Audited Results of Aurobindo Pharma Ltd. Company
(Rs in Cr.) |
Mar 31, 2023 |
Mar 31, 2022 |
Mar 31, 2021 |
Mar 31, 2020 |
Mar 31, 2019 |
Operating Income |
12,792.28 |
11,287.14 |
15,823.68 |
13,266.48 |
12,257.89 |
Manufacturing Expenses |
613.92 |
477.99 |
512.34 |
520.30 |
505.96 |
Personnel Expenses |
1,641.88 |
1,600.04 |
1,735.42 |
1,561.47 |
1,362.77 |
Selling Expenses |
0 |
0 |
0 |
0 |
0 |
Administrative Expenses |
1,795.57 |
1,754.34 |
2,030.53 |
1,806.54 |
1,616.92 |
Expenses Capitalised |
0 |
0 |
0 |
0 |
0 |
Cost Of Sales |
11,061.36 |
9,813.74 |
11,703.85 |
10,580.73 |
9,848.60 |
Operating Profit |
1,730.92 |
1,473.40 |
4,119.83 |
2,685.75 |
2,409.29 |
Other Recurring Income |
433.76 |
670.99 |
589.86 |
403.37 |
199.22 |
Adjusted PBDIT |
2,164.68 |
2,144.39 |
4,709.69 |
3,089.12 |
2,608.51 |
Financial Expenses |
114.98 |
16.94 |
28.68 |
240.94 |
230.86 |
Depreciation |
435.35 |
415.26 |
488 |
470.48 |
413.03 |
Other Write offs |
0 |
0 |
0 |
0 |
0 |
Adjusted PBT |
1,614.35 |
1,712.19 |
4,193.01 |
2,377.70 |
1,964.62 |
Tax Charges |
383.94 |
182.77 |
1,080.10 |
504.96 |
434.89 |
Adjusted PAT |
1,230.41 |
1,529.42 |
3,112.91 |
1,872.74 |
1,529.73 |
Non Recurring Items |
5.87 |
-73.02 |
-6.42 |
0 |
0 |
Other Non Cash adjustments |
0 |
0 |
0 |
0 |
0 |
Reported Net Profit |
1,230.41 |
1,454.71 |
3,112.91 |
1,872.74 |
1,529.73 |
Equity Dividend |
439.45 |
263.67 |
234.38 |
166.12 |
132.62 |
Preference Dividend |
0 |
0 |
0 |
0 |
0 |
Retained Earnings |
16,660.97 |
15,864.14 |
14,671.41 |
11,857.09 |
10,173.99 |